Views & Analysis Digital health round-up: can Xcertia clear the health app co... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis IBM Watson: a holistic approach to health Kyu Rhee, chief health officer, speaks about the company's impact and aspirations in health.
News Teva and IBM Watson team up for drug repurposing New three-year deal will use Watson to discover new indications for existing drugs.
Views & Analysis Digital Health Round-up – pharma to build Moonshot database,... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Digital Health Round-up – The Curious Case of Theranos, and ... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News IBM Watson and Siemens forge population health management al... Five-year, global strategic alliance aims to develop tools to improve chronic disease care.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.